Reaction
Renal Dysplasia reporting signals
As of the last recalculation, Renal Dysplasia appears in 379 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is ATAZANAVIR (PRR 119.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Atazanavir | 29 | 119.9 | 120.2 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 18 | 115.2 | 115.4 |
| Dolutegravir Sodium | 17 | 108.3 | 108.5 |
| Raltegravir | 29 | 104.4 | 104.5 |
| Nevirapine | 15 | 95.0 | 95.2 |
| Ritonavir 100 Mg | 23 | 89.9 | 90.1 |
| Ritonavir | 29 | 58.9 | 59.0 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 19 | 24.0 | 24.0 |